|
 |
Drug Research > NDA
The following information is about NDA.
NDA Defined
New Drug Application, a complete application (typically thousands of pages long) to the FDA (Food and Drug Administration) to begin marketing of a drug product in the US.
This definition is in context to Drug Research. See more contextual defintions for NDA.
CombinatoRx, Neuromed sign merger agreement
Published July 4, 2009, 2:48 am, PharmaBiz
CombinatoRx, Incorporated and Neuromed Pharmaceuticals, Inc., a privately-held biopharmaceutical company, announced they have entered into a definitive merger agreement under which CombinatoRx and Neuromed will merge in an all-stock transaction.
Current Status Of The Development Programs Of New Indications And Formulations For Aricept(R) For Enhancing Patient ...
Published July 3, 2009, 5:08 am, Medical News Today
Eisai Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito, "Eisai") and Eisai Corporation of North America (Headquarters: Woodcliff Lake, NJ, Chairman and CEO Hajime Shimizu) are currently focusing on three clinical development programs for the company's major product Aricept(R) (donepezil hydrochloride tablets) to further contribute to patients with Alzheimer's disease.
Acura And King Receive FDA Complete Response Letter Regarding Acurox(R)
Published July 3, 2009, 4:10 am, Medical News Today
Acura Pharmaceuticals, Inc. (Nasdaq: ACUR) and King Pharmaceuticals, Inc. (NYSE: KG) announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter regarding the New Drug Application (NDA) for Acurox (oxycodone HC1, USP and niacin, USP) Tablets CII, an immediate release product intended for the relief of moderate-to-severe pain.
My Pharmiweb.com
Published July 3, 2009, 3:19 am, PharmiWeb
Eisai Co ., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito, “Eisai”) is currently focusing on three clinical development programs related to its mainstay product Aricept® (donepezil hydrochloride) to further contribute to patients with Alzheimer’s disease.
Biogen Idec, Acorda enter pact to develop & commercialize MS therapy Fampridine-SR in outside US markets
Published July 3, 2009, 1:48 am, PharmaBiz
Biogen Idec and Acorda Therapeutics, Inc. announced that they have entered into an exclusive collaboration and license agreement to develop and commercialize Fampridine-SR, a multiple sclerosis (MS) therapy, in markets outside the United States.
Zacks Bull and Bear of the Day Highlights: AMAG Pharmaceuticals Inc., Palm, Inc. Everest Re, Ace Limited and Montpelier
Published July 2, 2009, 2:00 pm, Business Wire via Yahoo! Finance
CHICAGO----Zacks Equity Research highlights AMAG Pharmaceuticals Inc. as the Bull of the Day and Palm, Inc. the Bear of the Day. In addition, Zacks Equity Research provides analysis on Everest Re , Ace Limited and Montpelier .
CombinatoRx and Neuromed Sign Merger Agreement
Published July 2, 2009, 7:46 am, redOrbit
- Merger to Create a Sustainable Biotechnology Company: Brings Together Significant Product Assets, Unique Discovery Capabilities and Financial Resources - CAMBRIDGE, MA and VANCOUVER, BC, July 2 /PRNewswire/ - CombinatoRx, Incorporated (NASDAQ: CRXX) and Neuromed Pharmaceuticals, Inc., a privately-held biopharmaceutical company, today announced they have entered into a definitive merger ...
Acura and King Receive FDA Complete Response Letter Regarding Acurox(R)
Published July 2, 2009, 7:44 am, redOrbit
PALATINE, Ill. and BRISTOL, Tenn., July 2 /PRNewswire-FirstCall/ -- Acura Pharmaceuticals, Inc. (Nasdaq: ACUR) and King Pharmaceuticals, Inc. (NYSE: KG) announced today that the U.S.
Current Status of the Development Programs of New Indications and Formulations for Aricept(R) for Enhancing Patient ...
Published July 2, 2009, 7:44 am, redOrbit
TOKYO and WOODCLIFF LAKE, N.J., July 2 /PRNewswire/ -- Eisai Co., Ltd.
Stocks Tumble on Jobs News
Published July 2, 2009, 7:26 am, BusinessWeek
Stocks were trading solidly lower Thursday following the employment report, which didn't reveal any good news ahead of the long July 4 holiday weekend.
Are you looking for additional Drug Research > Nda news? Try our new "Nda News Focus" area.
Off-site NDA Links, User Submitted
The following links have been collected through user bookmark submission in the NDA category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Fri Jul 3
- Mytech - Mozilla: i numeri di Firefox 3.5: L?erede di Firefox 3 finalmente pronto: vediamo come si evoluto, cosa offre e come stato accolto dagli utenti.
- FriendDA -- Slightly more than a hearty handshake
Thu Jul 2
- boo.kmark.it - Flickr e il tagging automatico di Picnik: Modificando un'immagi ne tramite il servizio Picnik si pu ricevere una sorpresa: l'aggiunt a automatica di nuovi tag.
- What is important in a confidentialit y agreement or non-disclosure agreement (NDA)? : Startup Company Lawyer
Wed Jul 1
- Five reasons to drop NDAs
- FriendDA -- Slightly more than a hearty handshake: "WHEREAS I possess a bright idea that I am choosing to disclose to you, The Advisor, with the mutual understanding that you are my friend and that you will not screw me."
If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > NDA. If you would like to find related tags we recommend Tag Patterns > NDA
Off-site Nda Research Links
If you still need additional information on Nda then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Drug Research Topics
Everything you need to know about Drug Research
Drug Research
If you know the Drug Research Term Name use the links below to quickly jump to your desired focus.
Bookmark Us
The On Topic Network
This website is part of The On Topic Network.
Thank You
Drug-Research.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.
License
This work is licensed under Creative Commons.